Thomas Philip Richtarich serves as Executive at CALMARE THERAPEUTICS Inc, where they oversee executive responsibilities. Since joining the company, Thomas Philip Richtarich has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 12, 2018 involved receiving (via award) 333,333 shares valued at $30.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 12, 2018 | CTTC | $30.0K | Award | 333,333 | $0.09 | Discretionary |
Thomas Philip Richtarich currently holds 333,333 shares of CALMARE THERAPEUTICS Inc (CTTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Philip Richtarich has been a net neutral trader of CTTC stock. They have purchased $0 and sold $0 worth of shares.
Thomas Philip Richtarich's most recent insider trade was on Feb 12, 2018, when they sold 333,333 shares at $0.09 per share.
Get notified when new Form 4 filings are submitted